| __timestamp | Opthea Limited | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 1802274 |
| Thursday, January 1, 2015 | 2361587 | 2512761 |
| Friday, January 1, 2016 | 4472869 | 2894488 |
| Sunday, January 1, 2017 | 5030957 | 8096274 |
| Monday, January 1, 2018 | 4988941 | 7985229 |
| Tuesday, January 1, 2019 | 5196412 | 8994597 |
| Wednesday, January 1, 2020 | 6652774 | 29772000 |
| Friday, January 1, 2021 | 18418247 | 33907000 |
| Saturday, January 1, 2022 | 24827066 | 26579000 |
| Sunday, January 1, 2023 | 41896408 | 49868547 |
| Monday, January 1, 2024 | 15488619 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Opthea Limited and Verona Pharma plc, two prominent players, have shown distinct strategies over the past decade.
From 2014 to 2023, Opthea Limited's SG&A expenses grew by approximately 1,480%, peaking in 2023. In contrast, Verona Pharma plc saw a staggering increase of over 2,670% during the same period, with a notable spike in 2020. This suggests a more aggressive expansion or investment strategy by Verona.
Interestingly, data for Verona Pharma in 2024 is missing, leaving room for speculation on their future strategy. Will they continue their upward trend, or will they optimize costs?
Both companies have unique approaches to managing SG&A costs, reflecting their strategic priorities in a dynamic industry.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Verona Pharma plc
SG&A Efficiency Analysis: Comparing Catalent, Inc. and Verona Pharma plc
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Verona Pharma plc
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.